As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2018 about EMA Draft reflection paper: Investigation of pharmacokinetics and pharmacodynamics in the obese population can be found below.